Skip to main content
  • Original article
  • Open access
  • Published:

The impact of metabolic syndrome on ventilatory pulmonary Functions

Abstract

Background

A relationship between metabolic syndrome (MS) and lung disease has been observed in several cross-sectional and longitudinal studies. This syndrome has been identified as an independent risk factor for worsening respiratory symptoms and higher lung function impairment.

Aim

The aim of this study was to analyze the effect of MS on ventilatory pulmonary functions.

Patients and methods

This study included 60 participants. They were divided to two groups – group A included 45 patients with MS, and group B included 15 apparently healthy participants as a control group. All of them were subjected to the following: complete history taking and physical examination (blood pressure, BMI, and waist circumference), laboratory investigations for fasting blood glucose, lipid profile (triglyceride and high-density lipoprotein), C-reactive protein, and HbA1C, and spirometry [forced vital capacity (FVC), forced expiratory volume in first second (FEV1), and FEV1/FVC].

Results

Among MS participants (n=45), 28 (63%) had the restrictive ventilatory pattern, three (6%) had the obstructive pattern, nine (20%) were normal, and five (11%) had a mixed pattern. Pulmonary functions were impaired more among MS cases. FVC% predicted of group A was 61.49±17.56%, whereas in group B it was 85.73±5.24%. FEV1% predicted of group A was 66.22±18.7%, whereas in group B it was 87.73 ±7.98%. The differences were statistically highly significant. Pulmonary function impairment was more prominent among males than among females. After examining the association between metabolic components and both FVC% predicted and FEV1% predicted, the results revealed that there was a strong linear decrease in FVC% predicted and FEV1% predicted as the number of components of MS increased. The β coefficients of FVC% predicted for those with 1, 2, 3, 4, and 5 features of MS were 0.011, −0.018, −0.023, −0.035, and −0.048 in men and 0.020, −0.029, −0.035, −0.047, and −0.068 in women, respectively. The β coefficients of FEV1% predicted for those with 1, 2, 3, 4, and 5 features of MS were 0.009, −0.015, −0.026, −0.041, and −0.051 in men and 0.004, −0.009, −0.017, −0.029, and −0.038 in women, respectively.

Conclusion

Pulmonary function impairment (mainly restrictive pattern) is commonly associated with MS. FVC and FEV1 are inversely associated with the accumulation of elements of MS and also associated independently with each element of MS, especially waist circumference.

References

  1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC, Lenfant C, American Heart Association; National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433–438.

    Article  Google Scholar 

  2. Lin WY, Yao CA, Wang HC, Huang KC. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring) 2006; 14:1654–1661.

    Article  Google Scholar 

  3. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58:388–393.

    Article  CAS  Google Scholar 

  4. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia 2004; 47: 195–203.

    Article  CAS  Google Scholar 

  5. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 1472–1479.

    Article  Google Scholar 

  6. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253:574–581.

    Article  CAS  Google Scholar 

  7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respi J 2005; 26:319–338.

    Article  CAS  Google Scholar 

  8. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.

    Article  CAS  Google Scholar 

  9. Evans SE, Scanlon PD. Current practice in pulmonary function testing. Mayo Clin Proc 2003; 78:758–763.

    Article  Google Scholar 

  10. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Echel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112:2735–2752.

    Article  Google Scholar 

  11. Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23:469–480.

    Article  Google Scholar 

  12. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008; 31:1285–1293.

    Article  Google Scholar 

  13. Kawamoto R, Kohara K, Tabara Y, Miki T. An association between metabolic syndrome and the estimated glomerular filtration rate. Intern Med 2008; 47:1399–1406.

    Article  Google Scholar 

  14. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370:797–799.

    Article  Google Scholar 

  15. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thrommb Vasc Biol 2008; 28:27–38.

    Article  CAS  Google Scholar 

  16. Engstrom G, Hedblad B, Valind S, Janzon L. Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function. J Hypertens 2001; 19:295–301.

    Article  CAS  Google Scholar 

  17. McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung: 1. Epidemiology. Thorax 2008; 63:649–654.

    Article  CAS  Google Scholar 

  18. Rossi A, Fantin F, Di Francesco V, Guariento S, Giuliano K, Fontana G, et al. Body composition and pulmonary function in the elderly: a 7-year longitudinal study. Int J Obes (Lond) 2008; 32:1423–1430.

    Article  CAS  Google Scholar 

  19. Chen W-L, Wang C-C, Wu L-W, Kao TW, Chan JY, Chen YJ, et al. Relationship between lung function and metabolic syndrome. PLoS One 2014; 9:e108989.

  20. Choudhary PR, Jani Rameshchandra D. Study of pulmonary functions in patients with metabolic syndrome. Physiol Pharmacol 2016; 20: 90–97.

    Google Scholar 

  21. Lim SY, Rhee EJ, Sung KC. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci 2010; 25:1480–1486.

    Article  CAS  Google Scholar 

  22. Van Huisstede A, Cabezas MC, Birnie E, van de Geijn GJ, Rudolphus A, Mannaerts G, et al. Systemic inflammation and lung function impairment in morbidly obese subjects with the metabolic syndrome. J Obes 2013; 2013:131349.

    PubMed  PubMed Central  Google Scholar 

  23. Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444:881–887.

    Article  Google Scholar 

  24. Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol (1985) 2010; 108:206–211.

    Article  Google Scholar 

  25. Myoung-SookBae M-S, Han J-H, Kim J-H, Kim Y-J, Lee K-J, Kwon K-Y. The relationship between metabolic syndrome and pulmonary function. Korean J Fam Med 2012; 33:70–78.

    Article  Google Scholar 

  26. Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, et al. Lung function impairment and metabolic syndrome, the critical role of abdominal obesity. Am J Respir Crit Care Med 2009; 179:509–516.

    Article  Google Scholar 

  27. Lazarus R, Gore CJ, Booth M, Owen N. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998; 68:35–41.

    Article  CAS  Google Scholar 

  28. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Trevisan M, et al. Pulmonary function and abdominal adiposity in the general population. Chest 2006; 129:853–862.

    Article  Google Scholar 

  29. Harik-Khan RI, Wise RA, Fleg JL. The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol 2001; 54:399–406.

    Article  CAS  Google Scholar 

  30. Rogliani P, Curradi G, Mura M, Lauro D, Federici M, Galli A, et al. Metabolic syndrome and risk of pulmonary involvement. Respir Med 2010; 104:47–51.

    Article  Google Scholar 

  31. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96:1221–1232.

    Article  CAS  Google Scholar 

  32. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51:931–938.

    Article  CAS  Google Scholar 

  33. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006; 174:112–119.

    Article  Google Scholar 

  34. Poulain M, Doucet M, Major GC, Drapeau V, Series F, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 2006; 174: 1293–1299.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asmaa G. Shahoot MSc.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Negm, M.F., Essawy, T.S., Mohammad, O.I. et al. The impact of metabolic syndrome on ventilatory pulmonary Functions. Egypt J Bronchol 11, 293–300 (2017). https://doi.org/10.4103/ejb.ejb_82_16

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_82_16

Keywords